Speciality Medicines IPO Allotment Date
As per the timeline, the Speciality Medicines IPO allotment date is March 25, 2026, Wednesday. The investors can check the IPO allotment via the registrar website of Skylinerta or the BSE website. Investors can check the allotment status online and offline with easy steps given below:
Speciality Medicines IPO Allotment Links
| Registrar: | Skylinerta IPO Allotment Page |
| BSE: | BSE IPO Allotment Page |
| IPO Watch: | IPO Allotment Status Page |
Check Speciality Medicines’ IPO Allotment Status on Registrar site?
- Visit Skyline Financial Services Pvt. Ltd. website
- Select IPO Name ‘Speciality Medicines’ from the drop-down menu on the page
- Enter details required like PAN Card, Application Number, or Demat Account Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
Check Speciality Medicines IPO Allotment Status on BSE?
- Visit BSE India IPO Allotment Page
- Select the issue type: equity/debt
- Select IPO Name ‘Speciality Medicines’ from the drop-down menu on the page
- Enter details required like PAN Card or Application Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
IPO Subscription Details
| Category | Day 1 | Day 2 | Day 3 |
| QIB | 1.00 | 1.00 | 96.24 |
| NII | 1.60 | 1.68 | 1.88 |
| RII | 0.07 | 0.19 | 0.85 |
| Total | 0.84 | 0.94 | 2.27 |
Speciality Medicines IPO Key Dates
| IPO Open Date: | March 20, 2026 |
| IPO Close Date: | March 24, 2026 |
| Basis of Allotment: | March 25, 2026 |
| Refunds: | March 27, 2026 |
| Credit to Demat Account: | March 27, 2026 |
| IPO Listing Date: | March 30, 2026 |
Business Overview
One of the leading companies,ā Speciality Medicinesā was founded in 2021 and started a business of marketing and distribution of finished formulations of specialty pharmaceutical products, comprising high-cost oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology, and rare diseases.
Moreover, the company operates in two ways: (a) contract manufacturing of finished formulations for international markets, and (b) marketing and distribution of sourced specialty pharmaceutical products.
Further, the company has around 7 registered products overseas, and 54 products are in the registration process across 5 countries.
Note for the Investors
Speciality Medicines IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Speciality Medicines IPO Allotment date and time please contact the registrar with your queries.
